Kiniksa Pharmaceuticals News

Kiniksa Pharmaceuticals | DEFA14A: Others

Apr 23 16:50 ET

Kiniksa Pharmaceuticals | DEFA14A: Others

Apr 23 16:46 ET

Kiniksa Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 23 16:46 ET

Kiniksa Pharmaceuticals | DEF 14A: Definitive information statements

Apr 23 16:42 ET

Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Apr 23 07:39 ET

Kiniksa Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 10 17:03 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Patel Sanj K

Apr 8 17:24 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Paolini John F.

Apr 8 17:23 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ragosa Mark

Apr 8 17:23 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moat Ross

Apr 8 17:23 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Megna Michael R

Apr 8 17:23 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tessari Eben

Apr 8 17:19 ET

Kiniksa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.5%)

Apr 5 12:23 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ragosa Mark

Apr 3 17:30 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tessari Eben

Apr 3 17:29 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Megna Michael R

Apr 3 17:25 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Patel Sanj K

Apr 3 17:24 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moat Ross

Apr 3 17:24 ET

Kiniksa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Paolini John F.

Apr 3 17:24 ET

Kiniksa Pharmaceuticals | 8-K: Current report

Apr 2 07:34 ET